This page lists the plastic & reconstructive surgery hospitals in our directory offering Breast Lift Surgery in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.
Ask us about breast lift surgery in Chennai, India
Share a few details and our care coordination team will get back to you with next steps.
Compare 8 accredited hospitals for Plastic & Reconstructive Surgery in Chennai, India
Featured🇮🇳 Apollo Hospitals, Greams Road
Ranks #1 in this list by listed rating (4.7/5 from 125 reviews).
🇮🇳 Gleneagles Global Hospital
Ranks #2 in this list by listed rating (4.7/5 from 112 reviews).
🇮🇳 Dr. Rela Institute and Medical Centre
Ranks #3 in this list by listed rating (4.7/5 from 108 reviews).
🇮🇳 SIMS Hospital
Ranks #4 in this list by listed rating (4.6/5 from 20 reviews).
🇮🇳 Sankara Nethralaya
Ranks #5 in this list by listed rating (4.4/5 from 220 reviews).
🇮🇳 Apollo First Med Hospitals, Kilpauk
Ranks #6 in this list by listed rating (4.4/5 from 76 reviews).
🇮🇳 MIOT International
Ranks #7 in this list by listed rating (4.4/5 from 200 reviews).
🇮🇳 MGM Healthcare
Ranks #8 in this list by listed rating (3.7/5 from 34 reviews).
How we selected these hospitals
A hospital appears on this page when Plastic & Reconstructive Surgery is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Breast Lift Surgery in Chennai, India?
Choosing the right hospital for breast lift surgery is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include plastic & reconstructive surgery rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Breast Lift Surgery
Breast Lift Surgery (Mastopexy) is a precision cosmetic-reconstructive procedure that repositions descended breast tissue, removes excess skin, and reshapes the mammary envelope to restore a youthful, projected contour — with reported patient satisfaction rates consistently above 90% in high-volume centres. International patients choose India and the UAE through GAF Healthcare because both destinations offer board-certified plastic surgeons trained at globally accredited institutions, state-of-the-art operating theatres, and total treatment costs that represent a fraction of what the same procedure commands in the United States, United Kingdom, or Australia. GAF Healthcare coordinates every clinical and logistical detail — from pre-operative imaging and surgeon matching to post-operative physiotherapy and fit-to-fly certification — ensuring patients travel with confidence and return home safely. Hospital Stay: 1–2 days (day-surgery or overnight admission; longer if combined with augmentation or reduction) • Total Stay in Country (Fit-to-Fly): 2–3 weeks minimum before short/medium-haul flights; 3–4 weeks recommended for long-haul intercontinental travel • Success Rate: 91–95% patient satisfaction; complication rates below 5% at JCI/NABH/DHA-accredited centres
Clinical Overview
Breast ptosis — the clinical term for breast sagging — is a multifactorial anatomical condition characterised by inferior descent of the nipple-areola complex (NAC) relative to the inframammary fold (IMF), loss of upper-pole breast volume, and elongation of the skin envelope. It is graded using the Regnault Classification: Grade I (mild ptosis, nipple at the IMF level), Grade II (moderate ptosis, nipple 1–3 cm below the IMF), Grade III (severe ptosis, nipple more than 3 cm below the IMF and pointing inferiorly), and pseudoptosis (nipple above the IMF but with significant inferior pole gland descent). Causative factors include pregnancy, breastfeeding-related glandular involution, significant weight loss, hormonal changes at menopause, and gravitational effects on a large or heavy breast over time. Beyond aesthetics, clinically significant ptosis can cause chronic inframammary intertrigo, postural discomfort, brassiere-strap grooving of the shoulders, and psychosocial distress that measurably impairs quality-of-life scores on validated instruments such as the BREAST-Q questionnaire. Mastopexy addresses these concerns by surgically elevating and reshaping the breast parenchyma, excising redundant skin, and repositioning the NAC to a more anatomically superior, aesthetically pleasing location — typically 19–21 cm from the sternal notch and at the level of the mid-humerus. The procedure does not inherently add volume; if volume loss is a concurrent concern, mastopexy is combined with implant augmentation (augmentation-mastopexy) or autologous fat grafting using precision-harvested adipose tissue processed through closed-loop systems such as the Revolve or LipoKit platforms. The standard of care at JCI-accredited centres in India and the UAE includes pre-operative three-dimensional digital surface imaging (e.g., Vectra XT or Crisalix VR simulation) to set realistic patient expectations, intraoperative use of tumescent infiltration with dilute epinephrine and lidocaine to minimise blood loss, and layered closure with long-acting absorbable sutures (e.g., PDS II or Monocryl) to reduce tension on cutaneous scars. Perioperative anaesthesia protocols combine propofol-based total intravenous anaesthesia (TIVA) with multimodal analgesia — including local anaesthetic blocks, NSAIDs, and low-dose opioid sparing — to facilitate same-day or next-morning discharge and reduce post-operative nausea.
Who is a Candidate?
• IDEAL CANDIDATES: • Women aged 18 or older with fully developed breasts and stable body weight (within 10–15 kg of goal weight) for at least 6–12 months • Regnault Grade I, II, or III ptosis confirmed on clinical examination with NAC-to-IMF measurements • Patients who have completed childbearing, or who understand that future pregnancy can reverse surgical results • Non-smokers, or patients willing to abstain from nicotine (cigarettes, vaping, nicotine patches) for a minimum of 4 weeks pre-operatively and 4 weeks post-operatively — nicotine causes microvascular vasoconstriction and dramatically elevates the risk of NAC necrosis and wound dehiscence • BMI ≤ 32 kg/m² (patients with BMI 32–35 may be considered case-by-case with documented stable weight and no comorbid coagulopathy) • Psychologically stable with realistic, documented expectations assessed via standardised BREAST-Q pre-operative survey • No active breast malignancy — all candidates over 35 must provide a current mammogram (within 12 months) and/or breast ultrasound; those with BRCA1/BRCA2 carrier status require multidisciplinary oncology clearance before elective mastopexy • REQUIRED DIAGNOSTIC WORKUP (PERFORMED PRE-OPERATIVELY): • Mammogram (digital or tomosynthesis) and/or breast ultrasound: mandatory for patients ≥ 35 years or any age with a palpable mass or family history of breast cancer • Full blood count (FBC), coagulation screen (PT/aPTT/INR), metabolic panel, fasting glucose, HbA1c • Urine pregnancy test (mandatory for all women of reproductive age on day of surgery) • Baseline ECG for patients over 40 or those with cardiac history; anaesthesiology ECHO clearance if clinically indicated • Preoperative 3D digital imaging (Vectra XT or Crisalix) for surgical planning and expectation alignment — standard at GAF Healthcare partner hospitals • Patch testing if synthetic mesh (e.g., GalaFLEX P4HB scaffold) is planned for parenchymal support • CONTRAINDICATIONS (ABSOLUTE): • Active or recently treated breast malignancy without oncology clearance • Active systemic infection or skin infection overlying the breast • Uncontrolled diabetes mellitus (HbA1c > 8.0%) • Untreated coagulopathy or current anticoagulant therapy that cannot be safely bridged • Active smoker unwilling to cease nicotine at least 4 weeks pre-operatively • Autoimmune connective tissue disorders with significant microvascular involvement (relative contraindication — requires rheumatology clearance) • Unrealistic expectations or untreated body dysmorphic disorder (BDD) — BDD screening using the BDDQ instrument is mandatory at GAF Healthcare partner centres
Treatment Options & Approaches
MASTOPEXY TECHNIQUES — SELECTED BY PTOSIS GRADE AND BREAST MORPHOLOGY: 1. PERIAREOLAR (BENELLI / ROUND-BLOCK) MASTOPEXY Indicated for Grade I (mild) ptosis or pseudoptosis with minimal skin excess. A single doughnut-shaped excision is made around the areola; the NAC is elevated and the surrounding skin advanced and purse-string sutured with a permanent or long-lasting absorbable suture (e.g., 2-0 Gore-Tex or PDS). The scar is entirely confined to the areolar border (peri-areolar scar). Limitation: prone to areolar spreading and radial wrinkling if used beyond mild ptosis. 2. VERTICAL (LOLLIPOP) MASTOPEXY — Hall-Findlay or Lejour Technique The workhorse procedure for Grade II (moderate) ptosis. Incisions are periareolar plus a vertical limb running from the NAC to the IMF. The medial and lateral breast pillars are sutured together to create an internal brassiere of parenchymal tissue (auto-augmentation), elevating and reshaping the breast cone without implants. Scars: periareolar ring + vertical line. This technique avoids the horizontal IMF scar and is preferred in patients with good skin elasticity. 3. WISE-PATTERN (ANCHOR / INVERTED-T) MASTOPEXY Gold-standard for Grade III (severe) ptosis or cases with significant horizontal skin excess. Combines periareolar, vertical, and horizontal IMF incisions. Provides the greatest degree of lift, reshaping, and NAC repositioning. Scars form an anchor pattern. Highest scar burden but most powerful correction — appropriate for large, heavy, or significantly descended breasts. 4. AUGMENTATION-MASTOPEXY (COMBINED PROCEDURE) For patients with concurrent volume loss and ptosis. A cohesive silicone gel implant (form-stable 'gummy bear' implants, e.g., Mentor MemoryShape or Allergan Natrelle 410) or round high-projection implants are placed in a dual-plane (submuscular-subglandular) pocket simultaneously with the mastopexy. Alternatively, autologous fat grafting (Coleman lipofilling technique) using structured fat transfer is used to restore upper-pole volume without a foreign implant — increasingly preferred in patients who decline implants. This combination carries a higher complication risk than either procedure alone and requires a surgeon with specific combined-procedure experience. 5. AUTO-AUGMENTATION MASTOPEXY (IMPLANT-FREE VOLUME REDISTRIBUTION) The inferior pole parenchymal flap (de-epithelialised) is folded upward and sutured to the pectoralis fascia to fill the upper pole — providing a modest volume effect without a prosthesis. Best suited for patients with Grade II–III ptosis and adequate existing breast volume. Techniques include the Hall-Findlay superolateral pedicle variant and the Góes periareolar approach with mesh support. 6. MASTOPEXY WITH BIOABSORBABLE INTERNAL SCAFFOLD (GALAFLEX P4HB MESH) Next-generation approach where a knitted poly-4-hydroxybutyrate (P4HB) mesh scaffold (GalaFLEX) is sutured to the breast parenchyma to provide durable internal support, reducing the risk of long-term re-ptosis. The mesh is fully absorbed over approximately 18–24 months, by which time collagen ingrowth has consolidated the new breast shape. Particularly valuable in patients with thin, lax skin or in revision mastopexy cases. 7. NIPPLE-AREOLA COMPLEX (NAC) MANAGEMENT TECHNIQUES • Free nipple graft (FNG): Reserved for severe macromastia-associated ptosis where the NAC must travel more than 15–20 cm; sensory recovery is variable. • Superior pedicle, medial pedicle, or superomedial pedicle: Standard vascularised pedicle techniques that preserve sensation and lactation potential; pedicle selection depends on NAC transposition distance and surgeon training. ANESTHESIA AND TECHNOLOGY: • Total Intravenous Anaesthesia (TIVA) with BIS (Bispectral Index) monitoring for depth of anaesthesia • Tumescent infiltration: Dilute lidocaine 0.05% + epinephrine 1:400,000 for haemostasis • Intraoperative harmonic scalpel or LigaSure vessel sealing for reduced blood loss • Postoperative cryotherapy units and compression brassiere fitting before discharge • Enhanced Recovery After Surgery (ERAS) protocols: multimodal analgesia (paracetamol, ketorolac, dexamethasone, low-dose opioid PRN), early ambulation, anti-emetic prophylaxis (ondansetron + dexamethasone)
Recovery
PHASE 1 — PRE-OPERATIVE PREPARATION (4–8 WEEKS BEFORE SURGERY) • Step 1 (Remote): Patient submits medical history, photographs, and mammogram/ultrasound reports via the GAF Healthcare secure patient portal. A GAF-affiliated plastic surgeon reviews the case and issues a personalised surgical recommendation specifying technique (e.g., vertical mastopexy with superomedial pedicle), implant requirement (if any), and estimated operative time. • Step 2 (Remote): GAF Healthcare arranges a video consultation with the operating surgeon for expectation alignment and 3D simulation (Crisalix VR images shared digitally). • Step 3 (On Arrival — Day 1–2): Patient arrives at the GAF Healthcare partner hospital or clinic. In-person physical examination, breast measurements (sternal notch-to-nipple distance, base width, IMF mapping), blood tests, mammogram (if not recently performed), ECG, and anaesthesia pre-assessment are completed. • Step 4 (Day 2–3, Pre-Op): Surgeon performs detailed surgical markings in the upright standing position with permanent marker — a critical step unique to breast surgery where gravity must be accounted for. Patient signs informed consent covering all technique-specific risks. Pre-operative BREAST-Q completed. • Smoking cessation, aspirin/NSAID/herbal supplement cessation (minimum 2 weeks pre-op), and compression brassiere pre-fitting are completed. PHASE 2 — SURGERY DAY • Step 5 (Day 3–4): Patient admitted 2 hours before surgery. IV cannula inserted; anaesthesia team administers premedication (midazolam 1–2 mg IV, ondansetron 4 mg IV). Surgeon performs final standing markings review. • Step 6: TIVA induction with propofol and remifentanil; airway secured with laryngeal mask airway (LMA) or endotracheal tube for combined procedures. Tumescent infiltration applied. • Step 7: Surgical procedure performed — typical operative time: 2–2.5 hours for isolated mastopexy; 3–4 hours for augmentation-mastopexy. Layered wound closure; drains placed only if significant dissection performed (most isolated mastopexies are drain-free). Compression brassiere applied in theatre. • Step 8: Recovery room monitoring for 1–2 hours. Oral fluids commenced. Pain assessed using NRS (Numeric Rating Scale); multimodal analgesia initiated. Most patients are ambulant within 4 hours of surgery. PHASE 3 — IMMEDIATE POST-OPERATIVE PERIOD (Days 1–14 In-Country) • Day 1 post-op: Overnight admission for monitoring (vital signs, wound inspection, fluid balance). Shower and gentle mobilisation permitted Day 1 post-op with waterproof dressing. Compression brassiere worn 24/7. • Day 3–5: First wound review. Sutures are absorbable (Monocryl/PDS); no suture removal required in most cases. Early scar management with silicone gel sheets initiated. Bruising and swelling (oedema) are expected and peak at 72 hours. • Day 7: Second wound review, lymphatic drainage massage initiated if indicated. Patient given written fit-to-travel assessment criteria. • Day 10–14: Final pre-departure review. Surgeon issues a 'fit-to-fly' certificate with specific instructions: compression brassiere for travel, avoiding prolonged arm elevation, and DVT prophylaxis guidance (hydration, compression stockings, low-molecular-weight heparin if risk-stratified as high-risk). PHASE 4 — RECOVERY MILESTONES (POST-OPERATIVE WEEKS 2–12) • Week 2: Return to sedentary desk work; driving can resume once arm movement is full and pain-free (typically Week 3–4). • Week 3–4: Fit for short/medium-haul flight (< 6 hours). Long-haul intercontinental travel recommended after Week 4 minimum. • Week 4–6: Light walking and lower-body exercise permitted. Upper body, chest, and pectoral exercises strictly avoided until Week 8. • Week 6: Compression brassiere may be replaced with a supportive sports bra. Scar maturation begins; silicone sheets or gels continued for 6–12 months. • Week 8: Return to gym (non-chest exercises). Underwire brassiere can be reintroduced. • Week 12: Final shape begins to consolidate as swelling fully resolves. Upper-pole softening stabilises. BREAST-Q post-operative survey completed at 3 months. • Month 6–12: Scars continue to fade from pink/red to pale. Full scar maturation takes 12–18 months. GalaFLEX (if used) fully resorbed and replaced by native collagen scaffold.
Risks to be aware of
Mastopexy is a safe and well-established procedure when performed by a board-certified plastic surgeon in an accredited facility, but it carries both general anaesthetic risks and procedure-specific surgical risks that every patient must understand and consent to before proceeding. SURGERY-SPECIFIC RISKS: • Scarring: The most predictable and universal outcome. All mastopexy techniques produce permanent scars. In the majority of patients, scars fade significantly over 12–18 months, but hypertrophic or keloidal scarring can occur — particularly in patients with darker Fitzpatrick skin types (IV–VI) or a personal/family history of abnormal scarring. Pre-operative patch testing with silicone gel and early scar management are first-line preventive strategies. • Nipple-Areola Complex (NAC) sensory changes: Temporary or permanent reduction in nipple sensation occurs in 10–15% of patients depending on pedicle length and technique. Total NAC necrosis is rare (< 1%) but constitutes a serious complication requiring surgical debridement and potential reconstruction; it is most strongly associated with active smoking, diabetes, and excessively long pedicles. • Asymmetry: Minor degrees of residual breast asymmetry are common; significant asymmetry requiring revision occurs in approximately 3–8% of cases. • Wound dehiscence: Most commonly at the T-junction of Wise-pattern scars due to tension; managed with conservative wound care in most cases. • Haematoma: Collection of blood under the skin flaps; occurs in 1–3% of cases; may require surgical drainage. • Seroma: Fluid accumulation; managed with aspiration. • Infection: Surgical site infection rate < 2% with prophylactic antibiotics; risk elevated in diabetic or immunocompromised patients. • Changes to lactation potential: Mastopexy may affect the ability to breastfeed, particularly techniques that involve significant gland mobilisation or nipple transposition via short pedicles. Patients planning future breastfeeding should discuss pedicle selection explicitly with their surgeon. • Re-ptosis (recurrence): Gravity, ageing, and hormonal changes can cause the breast to re-descend over time. GalaFLEX scaffold support and maintenance of stable body weight are the primary strategies to prolong durability. • Deep Vein Thrombosis (DVT) / Pulmonary Embolism (PE): Risk is low for isolated mastopexy but increases with operative time > 3 hours, combined procedures, or patients with personal/family history of thromboembolism. Risk stratification using the Caprini Score is performed pre-operatively; high-risk patients receive pharmacological prophylaxis with low-molecular-weight heparin (e.g., enoxaparin). For patients travelling internationally, the additional consideration of long-haul flight DVT risk means that the timing of the return journey must be clinically cleared by the operating surgeon and should not be self-decided by the patient.
Why GAF Healthcare
GAF Healthcare provides a fully integrated medical tourism coordination service that extends well beyond surgical booking, addressing every non-clinical friction point that international patients face when travelling for elective procedures. VISA ASSISTANCE: • India: GAF Healthcare's coordination team assists patients in applying for the Indian e-Medical Visa (e-MV), which is processed online and typically approved within 1–4 business days. The e-MV allows a stay of up to 60 days (triple-entry) and is valid for patients travelling specifically for medical treatment. GAF provides the treating hospital's invitation letter, FRRO (Foreigners Regional Registration Office) registration guidance, and assistance with the Visa on Arrival process at designated international airports. • UAE (Dubai/Abu Dhabi): Citizens of over 50 countries are eligible for visa-free entry or visa-on-arrival into the UAE for 30–90 days. For patients from countries requiring prior approval, GAF Healthcare liaises with the partner hospital's international patient office to issue a treatment-linked visa facilitation letter through the DHA or DoH patient pathway. Patients from GCC countries face no visa requirement. AIRPORT TRANSFERS AND GROUND LOGISTICS: • Private, air-conditioned vehicle transfers from arrival airport to hospital and return to airport at discharge — bookable for both the patient and accompanying attendant. • For patients with limited mobility post-operatively, GAF arranges wheelchair assistance pre-notified to the airline and airport, and ensures vehicles are equipped with suitable seating for comfort post-surgery. ACCOMMODATION FOR PATIENT AND ATTENDANT: • GAF Healthcare has negotiated corporate rates with partner serviced apartments and hotels within 5–15 minutes of each treatment hospital, ranging from comfortable 3-star to luxury 5-star options based on patient preference and budget. • Attendant accommodation within hospital (in-room cot or adjoining room) is arranged at the time of hospital booking. • For the recovery period between hospital discharge and the fit-to-fly date, GAF arranges serviced apartments with access to cooking facilities, laundry, and 24-hour building security — essential for patients recovering over 2–3 weeks without family support infrastructure. DEDICATED PATIENT COORDINATOR AND TRANSLATION: • Every patient is assigned a dedicated GAF Healthcare Case Manager who is available via WhatsApp, email, and phone throughout the patient's journey — from initial inquiry through post-operative discharge. • Medical interpreters (Arabic, Russian, French, Swahili, Bahasa, and other languages) are available on-site or via secure video link at partner hospitals. • Medical records, discharge summaries, and follow-up instructions are translated into the patient's native language and shared digitally via the GAF secure portal for continuity of care with the patient's home country physician. POST-DEPARTURE FOLLOW-UP: • Virtual post-operative review consultations with the operating surgeon at 2 weeks, 6 weeks, and 3 months post-discharge are coordinated by GAF Healthcare. • Scar management product kits (medical-grade silicone sheets and gel) are either dispensed at discharge or shipped internationally to the patient's home address.
Common questions about Breast Lift Surgery
What is the cost of Breast Lift Surgery (Mastopexy) in India versus the UAE?
How long do I need to stay in the country before I am fit to fly home after Breast Lift Surgery?
What is the success rate of Breast Lift Surgery (Mastopexy) and how long do the results last?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Breast Lift Surgery in Chennai, India
Discover the Top Hospitals for Breast Lift Surgery in Chennai, India
This page lists 8 accredited plastic & reconstructive surgery hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Frequently asked questions about breast lift surgery in Chennai, India
How many plastic & reconstructive surgery hospitals are listed in Chennai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there plastic & reconstructive surgery hospitals for this in other India cities?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for breast lift surgery in Chennai, India.
Contact us to report an inaccuracy on this page.